3,4-dihydroxyphenylacetic acid has been researched along with Chronic Illness in 22 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intracerebral microdialysis was applied to monitor the neocortical extracellular levels of the aromatic amino acids phenylalanine, tyrosine, and tryptophan, the neurotransmitters dopamine (DA), noradrenaline (NA), and serotonin (5-HT), and the metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindole-3-acetic acid (5-HIAA) in rats with various forms of experimental hepatic encephalopathy (HE)." | 3.69 | Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt. ( Bengtsson, F; Bergqvist, PB; Bosman, DK; Chamuleau, RA; Hjorth, S; Maas, MA; Vogels, BA, 1995) |
| "The content and turnover of dopamine, 3,4-dihydroxyphenylacetic acid and norepinephrine have been investigated in the superior cervical, coeliac and mesenteric ganglia of rats exposed to moderate normobaric hypoxia (10% O2 in N2) lasting for 2-28 days." | 3.67 | Long-term hypoxia increases the turnover of dopamine but not norepinephrine in rat sympathetic ganglia. ( Cottet-Emard, JM; Dalmaz, Y; Pequignot, JM; Peyrin, L; Tavitian, E, 1988) |
| "Rosiglitazone is a commonly prescribed insulin-sensitizing drug with a selective agonistic activity on the peroxisome proliferator-activated receptor-gamma (PPAR-gamma)." | 1.35 | PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease. ( Caboni, P; Carboni, E; Carta, AR; Frau, L; Garau, A; Ibba, M; Schintu, N, 2009) |
| "Treatment with imipramine (10mg/kg i." | 1.33 | Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. ( Antoniou, K; Bekris, S; Daskas, S; Papadopoulou-Daifoti, Z, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (31.82) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schintu, N | 1 |
| Frau, L | 1 |
| Ibba, M | 1 |
| Caboni, P | 1 |
| Garau, A | 1 |
| Carboni, E | 1 |
| Carta, AR | 1 |
| Pais-Vieira, M | 1 |
| Mendes-Pinto, MM | 1 |
| Lima, D | 1 |
| Galhardo, V | 1 |
| Govitrapong, P | 1 |
| Boontem, P | 1 |
| Kooncumchoo, P | 1 |
| Pinweha, S | 1 |
| Namyen, J | 1 |
| Sanvarinda, Y | 1 |
| Vatanatunyakum, S | 1 |
| Pacak, K | 2 |
| Tjurmina, O | 1 |
| Palkovits, M | 2 |
| Goldstein, DS | 2 |
| Koch, CA | 1 |
| Hoff, T | 1 |
| Chrousos, GP | 1 |
| Kosten, TA | 1 |
| Zhang, XY | 1 |
| Kehoe, P | 1 |
| Pardon, MC | 1 |
| Hanoun, N | 1 |
| Perez-Diaz, F | 1 |
| Joubert, C | 1 |
| Launay, JM | 1 |
| Christen, Y | 1 |
| Hamon, M | 1 |
| Cohen-Salmon, C | 1 |
| Bekris, S | 1 |
| Antoniou, K | 1 |
| Daskas, S | 1 |
| Papadopoulou-Daifoti, Z | 1 |
| Baksi, SN | 1 |
| Hughes, MJ | 1 |
| Bergqvist, PB | 1 |
| Vogels, BA | 1 |
| Bosman, DK | 1 |
| Maas, MA | 1 |
| Hjorth, S | 1 |
| Chamuleau, RA | 1 |
| Bengtsson, F | 1 |
| Hantraye, P | 1 |
| Guibert, B | 1 |
| Biguet, NF | 1 |
| Lavergne, A | 1 |
| Leviel, V | 1 |
| Prell, GD | 1 |
| Green, JP | 1 |
| Elkashef, AM | 1 |
| Khandelwal, JK | 1 |
| Linnoila, M | 1 |
| Wyatt, RJ | 1 |
| Lawson, WB | 1 |
| Jaeger, AC | 1 |
| Kaufmann, CA | 1 |
| Kirch, DG | 1 |
| Pestana, M | 1 |
| Jardim, H | 1 |
| Serrão, P | 1 |
| Soares-da-Silva, P | 1 |
| Guerra, L | 1 |
| Fuertes, G | 1 |
| Laorden, ML | 1 |
| Milanés, MV | 1 |
| Hildebrand, BE | 1 |
| Svensson, TH | 1 |
| Rothblat, DS | 1 |
| Rubin, E | 1 |
| Schneider, JS | 1 |
| Armando, I | 1 |
| Fukuhara, K | 1 |
| Kvetnansky, R | 1 |
| Kopin, IJ | 1 |
| France, RD | 1 |
| Urban, BJ | 1 |
| Pelton, S | 1 |
| Kilts, CD | 1 |
| Hong, JS | 1 |
| Nemeroff, CB | 1 |
| Bagdy, G | 2 |
| Perényi, A | 2 |
| Frecska, E | 2 |
| Révai, K | 2 |
| Papp, Z | 1 |
| Fekete, MI | 1 |
| Arató, M | 1 |
| Contreras, SA | 1 |
| Maas, JW | 1 |
| Seleshi, E | 1 |
| Bowden, CL | 1 |
| Dalmaz, Y | 1 |
| Pequignot, JM | 1 |
| Tavitian, E | 1 |
| Cottet-Emard, JM | 1 |
| Peyrin, L | 1 |
| Cabib, S | 1 |
| Kempf, E | 1 |
| Schleef, C | 1 |
| Mele, A | 1 |
| Puglisi-Allegra, S | 1 |
1 trial available for 3,4-dihydroxyphenylacetic acid and Chronic Illness
| Article | Year |
|---|---|
Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Apomorphine; Chronic Disease; Clinical Trials as Topic; Diben | 1988 |
21 other studies available for 3,4-dihydroxyphenylacetic acid and Chronic Illness
| Article | Year |
|---|---|
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catalepsy; CD11b Antigen; Chromatography, High Pressure Liq | 2009 |
Cognitive impairment of prefrontal-dependent decision-making in rats after the onset of chronic pain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Chronic Disease; Cognition; Decision Making; Dise | 2009 |
Increased blood oxidative stress in amphetamine users.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Amphetamine-Related Disorders; Catalase; Chronic Disease; Dop | 2010 |
Chronic hypercortisolemia inhibits dopamine synthesis and turnover in the nucleus accumbens: an in vivo microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Chronic Disea | 2002 |
Chronic neonatal isolation stress enhances cocaine-induced increases in ventral striatal dopamine levels in rat pups.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Chronic Disease; Cocaine; Cocaine-Related | 2003 |
Long-term treatment with the antioxidant drug EGb 761 at senescence restored some neurobehavioral effects of chronic ultramild stress exposure seen in young mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Behavior, Animal; Brain; Brain Chemist | 2004 |
Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Beh | 2005 |
Chronic vitamin D deficiency in the weanling rat alters catecholamine metabolism in the cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cerebral Cortex; Cholecalciferol; Chronic Disease; Corpus S | 1982 |
Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Amino Acids; Ammonia; Animals; Biogenic Monoamines; B | 1995 |
TH mRNA over-expression in rats with chronic excitotoxic striatal lesions.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Diseases; Caudate Nucleus; Chronic Disease; Co | 1994 |
The relationship between urine excretion and biogenic amines and their metabolites in cerebrospinal fluid of schizophrenic patients.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Biogenic Amines; Chronic Disease; Drinking; Female; Histamine | 1996 |
Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Biopsy; Catechol O-Methyltransferase; Chromatography, H | 1998 |
Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Chroni | 2000 |
Intraaccumbal mecamylamine infusion does not affect dopamine output in the nucleus accumbens of chronically nicotine-treated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Chronic Disease; Dopamine; Extracellular | 2000 |
Effects of chronic alcohol ingestion on the mesostriatal dopamine system in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol-Induced Disorders, Nervous System; Animals; Carrier Proteins | 2001 |
Noradrenergic activation in the paraventricular nucleus during acute and chronic immobilization stress in rats: an in vivo microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Animals; Chronic Disease; Dialysis; Disease Models, A | 1992 |
CSF monoamine metabolites in chronic pain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Back Pain; Biogenic Amines; Chronic Disease; Depressive | 1987 |
Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antipsychotic Agents; Chronic Disease; Dopamine; Female; Halo | 1985 |
CSF dopamine turnover and positive schizophrenic symptoms after withdrawal of long-term neuroleptic treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antipsychotic Agents; Brain; Chronic Disease; Dopamine; Femal | 1985 |
Long-term hypoxia increases the turnover of dopamine but not norepinephrine in rat sympathetic ganglia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chronic Disease; Dopamine; Ganglia, Sympathetic; Hypoxia; M | 1988 |
Different effects of acute and chronic stress on two dopamine-mediated behaviors in the mouse.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Animals; Apomorphine; Brain; Caudate Nucleus; Chronic | 1988 |